查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571847

全球血糖监测系统市场

Blood Glucose Monitoring Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 92 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球血糖监测系统市场预计将达到 400 亿美元

2023年全球血糖监测系统市场估计为208亿美元，预计2030年将达到400亿美元，2023年至2030年复合年增长率为9.8%。自我监测是本报告分析的细分市场之一，预计复合年增长率为 9.3%，到分析期结束时将达到 214 亿美元。分析期间，连续细分市场的复合年增长率预计为 10.5%。

美国市场预计54亿美元，中国预计复合年增长率13.0%

预计2023年美国血糖监测系统市场规模将达54亿美元。中国作为世界第二大经济体，预计2030年市场规模将达91亿美元，2023-2030年分析期间复合年增长率为13.0%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 6.7% 和 7.9%。在欧洲，德国的复合年增长率预计约为 7.5%。

全球血糖监测系统市场—主要趋势与驱动因素总结

血糖监测系统如何随着科技的进步而发展？

由于技术进步使血糖监测对糖尿病患者来说更加准确、方便和用户友好，血糖监测 (BGM) 系统市场正在经历重大发展。传统的血糖值监测方法，例如指尖刺血液测试，正在被连续血糖监测 (CGM) 系统所取代，该系统具有微创性，可即时追踪血糖浓度。 CGM 系统透过插入皮下的感测器连续测量血糖浓度，使患者和医疗保健提供者能够更准确地监测趋势和波动。这种从间歇监测到连续监测的转变透过允许及时干预和更个人化的治疗计划来改善糖尿病管理。

整合 CGM 技术的可穿戴设备也越来越受欢迎，为患者提供了一种方便、非侵入性的方式来追踪全天的血糖值。这些设备通常连接到行动应用程序，允许用户即时查看血糖资料，接收有关危险波动的警报，并与医疗保健提供者共用资讯。此外，人工智慧 (AI) 和资料分析的进步透过启用预测模型来预测血糖波动并帮助患者采取预防措施，从而提高血糖监测系统的准确性。

CGM 系统如何影响糖尿病管理？

连续血糖监测 (CGM) 系统透过提供更详细的即时血糖浓度资料，对糖尿病管理产生重大影响。与传统的血糖仪需要全天多次进行指尖采血测试不同，CGM 系统提供连续的资料流，使用户能够监测血糖趋势和模式。这种即时监测使患者能够确定不同的活动、饮食和药物如何影响他们的血糖水平，使他们能够就降低饮食、运动和胰岛素的使用做出明智的决定。

CGM 系统还可以在血糖浓度过高或过低时发送警报，从而提高患者的安全性，有助于防止高血糖或低血糖的危险发作。这项功能对于血糖快速波动风险较高的第 1 型糖尿病患者尤其有益。 CGM 系统还允许医疗保健提供者随时存取详细的血糖资料，从而更准确地评估和调整治疗计划。透过提高血糖资料的品质和频率，CGM 系统正在改变糖尿病护理并改善全球数百万患者的治疗结果。

与行动应用程式和人工智慧的资料整合如何改善血糖监测？

与行动应用程式和人工智慧的资料整合极大地提高了血糖监测系统的功能，使糖尿病管理更加便利和个人化。许多现代血糖监测仪和 CGM 设备都包含蓝牙技术，使它们能够与智慧型手机应用程式同步，从而允许用户追踪和管理血糖浓度。这些应用程式通常提供视觉化图表、历史资料和趋势分析，以帮助用户了解他们随时间变化的血糖模式。一些应用程式可以记录您的膳食、身体活动和药物治疗，让您整体情况糖尿病管理情况。

人工智慧驱动的演算法透过分析过去的资料并根据过去的趋势预测未来的血糖水平，增强了血糖监测系统的预测能力。这使得患者能够预测血糖的峰值和下降，并相应地调整他们的行为和胰岛素剂量。人工智慧也被用于开发封闭回路型胰岛素输送系统，也称为人工胰臟系统，可根据即时血糖测量结果自动调整胰岛素水平。资料整合和人工智慧的这些进步使血糖监测更加主动，减轻了患者的负担并改善了整体糖尿病管理。

推动血糖监测系统市场成长的因素有哪些？

血糖监测系统市场的成长是由多种因素推动的，例如全球糖尿病盛行率的增加、血糖监测技术的进步以及穿戴式装置的日益普及。随着全球糖尿病盛行率持续上升，特别是在开发中国家，对有效的血糖监测解决方案来帮助患者管理疾病的需求不断增长。从传统的指尖采血测试向连续血糖监测 (CGM) 系统的转变是一个主要驱动力，因为这些设备提供了更准确、即时的资料并减少了侵入性测试的需求。

CGM 系统和行动应用程式整合、人工智慧和资料分析等技术进步也使血糖监测变得更加方便、准确和个人化，从而推动市场成长。穿戴式装置的日益普及也促进了市场的扩张，因为消费者越来越喜欢非侵入性和互联的健康管理解决方案。此外，人口老化、久坐生活方式的增加和不健康的饮食导致第 2 型糖尿病盛行率增加，进一步推动了对血糖监测系统的需求。

CGM 系统的监管支援和报销政策也在推动采用，特别是在北美和欧洲等新兴市场。医疗保健提供者和保险公司正在认识到 CGM 系统在改善糖尿病管理和降低与糖尿病併发症相关的长期成本方面的价值。最后，随着患者更主动地管理疾病和预防併发症，人们对糖尿病和血糖监测重要性的认识不断提高，这些系统得到了更多的采用。

受访企业范例（共36家）

  • Abbott Laboratories
  • Acon Laboratories
  • Arkray
  • Ascensia Diabetes Care
  • B. Braun Melsungen
  • Dexcom
  • F. Hoffmann-La Roche
  • Lifescan
  • Medtronic

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP21367

Global Blood Glucose Monitoring Systems Market to Reach US$40.0 Billion by 2030

The global market for Blood Glucose Monitoring Systems estimated at US$20.8 Billion in the year 2023, is expected to reach US$40.0 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2023-2030. Self-Monitoring, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$21.4 Billion by the end of the analysis period. Growth in the Continuous segment is estimated at 10.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.4 Billion While China is Forecast to Grow at 13.0% CAGR

The Blood Glucose Monitoring Systems market in the U.S. is estimated at US$5.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$9.1 Billion by the year 2030 trailing a CAGR of 13.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Global Blood Glucose Monitoring Systems Market – Key Trends & Drivers Summarized

How Are Blood Glucose Monitoring Systems Evolving with Technological Advancements?

The blood glucose monitoring (BGM) systems market is undergoing significant evolution due to advancements in technology, which are making glucose monitoring more accurate, convenient, and user-friendly for patients with diabetes. Traditional methods of monitoring blood glucose levels, such as finger-prick tests, are being replaced by continuous glucose monitoring (CGM) systems that offer real-time tracking of glucose levels with minimal invasiveness. CGM systems use sensors inserted under the skin to measure glucose levels continuously, allowing patients and healthcare providers to monitor trends and fluctuations more accurately. This shift from intermittent to continuous monitoring is improving diabetes management by enabling timely interventions and more personalized treatment plans.

Wearable devices integrated with CGM technology are also gaining popularity, providing patients with a convenient, non-invasive way to track their blood glucose levels throughout the day. These devices are often connected to mobile apps, allowing users to view their glucose data in real-time, receive alerts about dangerous fluctuations, and share information with their healthcare providers. Additionally, advancements in artificial intelligence (AI) and data analytics are enhancing the accuracy of blood glucose monitoring systems by enabling predictive modeling, which can anticipate glucose fluctuations and help patients take preventive measures.

What Impact Do CGM Systems Have on Diabetes Management?

Continuous Glucose Monitoring (CGM) systems are having a profound impact on diabetes management by offering more detailed and real-time data on glucose levels, allowing patients to take proactive steps in managing their condition. Unlike traditional blood glucose meters, which require multiple finger-stick tests throughout the day, CGM systems provide a continuous stream of data, enabling users to monitor glucose trends and patterns. This real-time monitoring allows patients to identify how different activities, meals, and medications affect their glucose levels, helping them make informed decisions about their diet, exercise, and insulin use.

CGM systems also enhance safety for patients by sending alerts when glucose levels are too high or too low, helping to prevent dangerous episodes of hyperglycemia or hypoglycemia. This feature is particularly beneficial for patients with type 1 diabetes, who are at greater risk of sudden glucose fluctuations. CGM systems also enable healthcare providers to access detailed glucose data over time, allowing for more accurate assessments and adjustments to treatment plans. By improving the quality and frequency of glucose data, CGM systems are transforming diabetes care and improving outcomes for millions of patients worldwide.

How Is Data Integration with Mobile Apps and AI Improving Blood Glucose Monitoring?

Data integration with mobile apps and AI is significantly improving the functionality of blood glucose monitoring systems, making diabetes management more convenient and personalized. Many modern glucose monitors and CGM devices are now equipped with Bluetooth technology, allowing them to sync with smartphone apps where users can track and manage their glucose levels. These apps often provide visual charts, historical data, and trend analysis, helping users understand their glucose patterns over time. Some apps also allow users to log meals, physical activity, and medications, providing a holistic view of their diabetes management.

AI-powered algorithms are enhancing the predictive capabilities of blood glucose monitoring systems by analyzing historical data and predicting future glucose levels based on past trends. This can help patients anticipate glucose spikes or drops and adjust their behavior or insulin dosing accordingly. AI is also being used to develop closed-loop insulin delivery systems, also known as artificial pancreas systems, which automatically adjust insulin levels in response to real-time glucose readings. These advancements in data integration and AI are making blood glucose monitoring more proactive, reducing the burden on patients and improving overall diabetes management.

What Factors Are Driving the Growth of the Blood Glucose Monitoring Systems Market?

The growth in the blood glucose monitoring systems market is driven by several factors, including the increasing prevalence of diabetes worldwide, advancements in glucose monitoring technology, and the growing adoption of wearable devices. As the global incidence of diabetes continues to rise, particularly in developing countries, there is a growing demand for effective glucose monitoring solutions that help patients manage their condition. The shift from traditional finger-stick testing to continuous glucose monitoring (CGM) systems is a key growth driver, as these devices offer more accurate, real-time data and reduce the need for invasive testing.

Technological advancements, such as the integration of CGM systems with mobile apps, AI, and data analytics, are also driving market growth by making glucose monitoring more convenient, accurate, and personalized. The growing popularity of wearable devices is another factor contributing to the expansion of the market, as consumers increasingly prefer non-invasive, connected solutions for managing their health. In addition, the aging population and the rise in sedentary lifestyles and unhealthy diets are leading to an increased prevalence of type 2 diabetes, further fueling the demand for blood glucose monitoring systems.

Regulatory support and reimbursement policies for CGM systems are also driving adoption, particularly in developed markets such as North America and Europe. Healthcare providers and insurance companies are recognizing the value of CGM systems in improving diabetes management and reducing the long-term costs associated with diabetes complications. Finally, increasing awareness about diabetes and the importance of glucose monitoring is leading to greater adoption of these systems, as patients become more proactive in managing their condition and preventing complications.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Acon Laboratories
  • Arkray
  • Ascensia Diabetes Care
  • B. Braun Melsungen
  • Dexcom
  • F. Hoffmann-La Roche
  • Lifescan
  • Medtronic

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Blood Glucose Monitoring Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Globally Drives Demand for Blood Glucose Monitoring Systems
    • Increasing Focus on Personalized Healthcare Expands the Addressable Market for Continuous Glucose Monitoring (CGM) Systems
    • Technological Advancements in Blood Glucose Monitoring Devices Propel Growth in Accuracy and Usability
    • Growing Demand for Wearable and Non-Invasive Blood Glucose Monitoring Devices Fuels Innovation
    • Rising Awareness of Diabetes Management and Preventive Care Strengthens Market Growth for Blood Glucose Monitors
    • Integration of AI and Data Analytics in Glucose Monitoring Systems Expands Opportunities for Personalized Treatment
    • Increasing Focus on Remote Patient Monitoring and Telehealth Solutions Expands Market Adoption of Blood Glucose Monitoring Systems
    • Growing Use of Continuous Glucose Monitoring Systems in Pediatric and Geriatric Diabetes Management Drives Demand
    • Rising Adoption of Smart Insulin Pens and Automated Insulin Delivery Systems Propels Demand for Integrated Monitoring Solutions
    • Increasing Use of Blood Glucose Monitoring Systems in Hospital and Clinical Settings Expands Market Applications
    • Technological Advancements in Sensor Accuracy and Battery Life Strengthen the Business Case for Wearable Glucose Monitors
    • Rising Demand for Glucose Monitoring Apps and Digital Health Platforms Drives Adoption of Connected Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Blood Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Self-Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Self-Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Self-Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Continuous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Continuous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Continuous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Fingertip Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Fingertip Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Fingertip Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Alternate Site Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Alternate Site Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Alternate Site Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Self / Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Self / Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Self / Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Type 1 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Type 1 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Type 1 Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Type 2 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Type 2 Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Type 2 Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Blood Glucose Monitoring Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: China 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Blood Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: France 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: France 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: France 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Germany 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Germany 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Italy 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Italy 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Italy 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 131: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: UK 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 134: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: UK 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: UK 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: UK 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 143: Spain Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Spain Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Spain 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 146: Spain Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Spain 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Spain 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Spain 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 155: Russia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Russia Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Russia 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Russia 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Russia 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Russia 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Rest of Europe 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 180: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 194: Australia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Australia Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Australia 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 197: Australia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Australia Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Australia 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Australia 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Australia 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 206: India Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: India Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: India 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 209: India Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: India Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: India 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 212: India Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: India 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: India 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 218: South Korea Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: South Korea Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: South Korea 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 221: South Korea Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: South Korea Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: South Korea 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: South Korea 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: South Korea 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 230: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 242: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 243: Latin America Historic Review for Blood Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 245: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Latin America Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 257: Argentina Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Argentina Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Argentina 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 260: Argentina Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Argentina Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Argentina 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Argentina 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Argentina 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 269: Brazil Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Brazil Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Brazil 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 272: Brazil Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Brazil Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Brazil 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: Brazil 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: Brazil 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 281: Mexico Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: Mexico Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: Mexico 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 284: Mexico Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Mexico Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Mexico 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Mexico 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Mexico 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 293: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Rest of Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 304: Rest of Latin America 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 305: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 306: Middle East Historic Review for Blood Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 307: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 308: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 309: Middle East Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 310: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 313: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 316: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 319: Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 320: Iran Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 321: Iran Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 322: Iran 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 323: Iran Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 324: Iran Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 325: Iran 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 328: Iran 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 331: Iran 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 332: Israel Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 333: Israel Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 334: Israel 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 335: Israel Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 336: Israel Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 337: Israel 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 340: Israel 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 343: Israel 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 344: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 345: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 346: Saudi Arabia 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 348: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 349: Saudi Arabia 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 352: Saudi Arabia 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 355: Saudi Arabia 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 356: UAE Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 357: UAE Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 358: UAE 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 359: UAE Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 360: UAE Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 361: UAE 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 364: UAE 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 367: UAE 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 368: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 369: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 370: Rest of Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 372: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 373: Rest of Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 376: Rest of Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 379: Rest of Middle East 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Blood Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 380: Africa Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 381: Africa Historic Review for Blood Glucose Monitoring Systems by Product - Self-Monitoring and Continuous Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 382: Africa 16-Year Perspective for Blood Glucose Monitoring Systems by Product - Percentage Breakdown of Value Sales for Self-Monitoring and Continuous for the Years 2014, 2024 & 2030
    • TABLE 383: Africa Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 384: Africa Historic Review for Blood Glucose Monitoring Systems by Testing Site - Fingertip Testing and Alternate Site Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 385: Africa 16-Year Perspective for Blood Glucose Monitoring Systems by Testing Site - Percentage Breakdown of Value Sales for Fingertip Testing and Alternate Site Testing for the Years 2014, 2024 & 2030
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Blood Glucose Monitoring Systems by Patient Care Setting - Self / Home Care and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 388: Africa 16-Year Perspective for Blood Glucose Monitoring Systems by Patient Care Setting - Percentage Breakdown of Value Sales for Self / Home Care and Hospitals & Clinics for the Years 2014, 2024 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Blood Glucose Monitoring Systems by Application - Type 1 Diabetes, Type 2 Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 391: Africa 16-Year Perspective for Blood Glucose Monitoring Systems by Application - Percentage Breakdown of Value Sales for Type 1 Diabetes, Type 2 Diabetes and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION